220 related articles for article (PubMed ID: 27156771)
1. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
[TBL] [Abstract][Full Text] [Related]
2. Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
Gajdács M; Spengler G; Sanmartín C; Marć MA; Handzlik J; Domínguez-Álvarez E
Bioorg Med Chem Lett; 2017 Feb; 27(4):797-802. PubMed ID: 28126516
[TBL] [Abstract][Full Text] [Related]
3. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
[TBL] [Abstract][Full Text] [Related]
4. Phenothiazines and Selenocompounds: A Potential Novel Combination Therapy of Multidrug Resistant Cancer.
GajdÁcs M; NovÉ M; Csonka Á; Varga B; SanmartÍn C; DomÍnguez-Álvarez E; Spengler G
Anticancer Res; 2020 Sep; 40(9):4921-4928. PubMed ID: 32878780
[TBL] [Abstract][Full Text] [Related]
5. An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.
Żesławska E; Kucwaj-Brysz K; Kincses A; Spengler G; Szymańska E; Czopek A; Marć MA; Kaczor A; Nitek W; Domínguez-Álvarez E; Latacz G; Kieć-Kononowicz K; Handzlik J
Bioorg Chem; 2021 Apr; 109():104735. PubMed ID: 33640632
[TBL] [Abstract][Full Text] [Related]
6. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
[TBL] [Abstract][Full Text] [Related]
8. Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death induction.
Reis MA; Ahmed OB; Spengler G; Molnár J; Lage H; Ferreira MJ
Phytomedicine; 2016 Aug; 23(9):968-78. PubMed ID: 27387405
[TBL] [Abstract][Full Text] [Related]
9. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
10. Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs-A Promising Approach to Fight Cancer Drug Resistance.
Spengler G; Gajdács M; Marć MA; Domínguez-Álvarez E; Sanmartín C
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669343
[TBL] [Abstract][Full Text] [Related]
11. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
Kim MK; Kim Y; Choo H; Chong Y
Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
[TBL] [Abstract][Full Text] [Related]
12. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
Molecules; 2020 May; 25(9):. PubMed ID: 32403277
[TBL] [Abstract][Full Text] [Related]
13. The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological studies.
Żesławska E; Kincses A; Spengler G; Nitek W; Wyrzuc K; Kieć-Kononowicz K; Handzlik J
Bioorg Med Chem; 2016 Jun; 24(12):2815-22. PubMed ID: 27160056
[TBL] [Abstract][Full Text] [Related]
14. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
Feng SL; Yuan ZW; Yao XJ; Ma WZ; Liu L; Liu ZQ; Xie Y
Pharmacol Res; 2016 Aug; 110():193-204. PubMed ID: 27058921
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
Spengler G; Ocsovszki I; Tönki ÁS; Saijo R; Watanabe G; Kawase M; Molnár J
Anticancer Res; 2015 Nov; 35(11):5915-9. PubMed ID: 26504015
[TBL] [Abstract][Full Text] [Related]
16. Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
Stark M; Assaraf YG
Oncotarget; 2017 Jul; 8(30):49973-49987. PubMed ID: 28637003
[TBL] [Abstract][Full Text] [Related]
17. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
18. Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance.
Wang B; Zhao B; Chen ZS; Pang LP; Zhao YD; Guo Q; Zhang XH; Liu Y; Liu GY; Hao-Zhang ; Zhang XY; Ma LY; Liu HM
Eur J Med Chem; 2018 Jan; 143():1535-1542. PubMed ID: 29126726
[TBL] [Abstract][Full Text] [Related]
19. Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents.
Zhu J; Wang R; Lou L; Li W; Tang G; Bu X; Yin S
J Med Chem; 2016 Jul; 59(13):6353-69. PubMed ID: 27328029
[TBL] [Abstract][Full Text] [Related]
20. HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).
Köhler SC; Wiese M
J Med Chem; 2015 May; 58(9):3910-21. PubMed ID: 25855895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
